News
A Stanford-led study found that most AI chatbots have stopped including medical disclaimers in health responses, raising ...
A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...
Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...
Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...
Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...
Once cautious, OpenAI, Grok, and others will now dive into giving unverified medical advice with virtually no disclaimers.
Rather than chase enterprise contracts with large hospital systems, Freed has focused on small clinics and solo practitioners.
OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...
It’s a sentiment felt widely across the medical field as AI starts to touch nearly every corner of medical research, physician training and processes, and patient care. The rollout of AI across health ...
According to a survey of 2,000 U.S. adults, a little more than a third (35%) already use AI to learn about and manage aspects ...
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...
After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results